The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation.

Autor: Taube JM; Department of Dermatology, Johns Hopkins School of Medicine, Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA jtaube1@jhmi.edu., Akturk G; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York City, USA., Angelo M; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA., Engle EL; Department of Dermatology, Johns Hopkins School of Medicine, Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Gnjatic S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York City, USA., Greenbaum S; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA., Greenwald NF; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA.; Cancer Biology Program, Stanford University School of Medicine, Palo Alto, California, USA., Hedvat CV; Bristol-Myers Squibb, New York, New York City, USA., Hollmann TJ; Dermatopathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Juco J; Merck & Co Inc, Kenilworth, New Jersey, USA., Parra ER; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rebelatto MC; AstraZeneca, Gaithersburg, Maryland, USA., Rimm DL; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA., Rodriguez-Canales J; AstraZeneca, Gaithersburg, Maryland, USA., Schalper KA; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA., Stack EC; Jounce Therapeutics Inc, Cambridge, Massachusetts, USA., Ferreira CS; Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany., Korski K; Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany., Lako A; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Rodig SJ; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Schenck E; AstraZeneca, Gaithersburg, Maryland, USA., Steele KE; AstraZeneca, Gaithersburg, Maryland, USA., Surace MJ; AstraZeneca, Gaithersburg, Maryland, USA., Tetzlaff MT; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., von Loga K; Biomedical Research Centre, Royal Marsden NHS Foundation Trust, London, UK., Wistuba II; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bifulco CB; Providence Portland Medical Center, Portland, Oregon, USA.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2020 May; Vol. 8 (1).

Sphingosine-1-phosphate inhibits IL-1-induced expression of C-C motif ligand 5 via c-Fos-dependent suppression of IFN-β amplification loop.

Autor: Yester JW; Department of Biochemistry and Molecular Biology, Department of Physiology and Biophysics, and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Bryan L; Department of Biochemistry and Molecular Biology, Department of Physiology and Biophysics, and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Waters MR; Department of Biochemistry and Molecular Biology, Department of Physiology and Biophysics, and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Mierzenski B; Department of Biochemistry and Molecular Biology, Department of Physiology and Biophysics, and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Biswas DD; Department of Biochemistry and Molecular Biology, Department of Physiology and Biophysics, and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Gupta AS; Department of Biochemistry and Molecular Biology, Department of Physiology and Biophysics, and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Bhardwaj R; Department of Biochemistry and Molecular Biology, Department of Physiology and Biophysics, and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Surace MJ; Department of Biochemistry and Molecular Biology, Department of Physiology and Biophysics, and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Eltit JM; Department of Biochemistry and Molecular Biology, Department of Physiology and Biophysics, and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Milstien S; Department of Biochemistry and Molecular Biology, Department of Physiology and Biophysics, and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Spiegel S; Department of Biochemistry and Molecular Biology, Department of Physiology and Biophysics, and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Kordula T; Department of Biochemistry and Molecular Biology, Department of Physiology and Biophysics, and Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA tkordula@vcu.edu.

Publikováno v: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2015 Dec; Vol. 29 (12), pp. 4853-65. Date of Electronic Publication: 2015 Aug 05.

K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5.

Autor: Harikumar KB; Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Yester JW; Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Surace MJ; Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Oyeniran C; Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Price MM; Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Huang WC; Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Hait NC; Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Allegood JC; Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Yamada A; 1] Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA. [2] Department of Surgery and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Kong X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China., Lazear HM; Department of Medicine, Department of Molecular Microbiology and Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USA., Bhardwaj R; Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Takabe K; 1] Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA. [2] Department of Surgery and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Diamond MS; Department of Medicine, Department of Molecular Microbiology and Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USA., Luo C; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China., Milstien S; Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Spiegel S; Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Kordula T; Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.

Publikováno v: Nature immunology [Nat Immunol] 2014 Mar; Vol. 15 (3), pp. 231-8. Date of Electronic Publication: 2014 Jan 26.

Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.

Autor: Surace MJ; Department of Anatomy and Neurobiology, Virginia Commonwealth University Medical Campus, Richmond, 23298, USA., Block ML

Publikováno v: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2012 Jul; Vol. 69 (14), pp. 2409-27. Date of Electronic Publication: 2012 May 13.

Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity.

Autor: Levesque S; Department of Anatomy and Neurobiology, Virginia Commonwealth University Medical Campus, Richmond, Virginia, USA., Taetzsch T, Lull ME, Kodavanti U, Stadler K, Wagner A, Johnson JA, Duke L, Kodavanti P, Surace MJ, Block ML

Publikováno v: Environmental health perspectives [Environ Health Perspect] 2011 Aug; Vol. 119 (8), pp. 1149-55. Date of Electronic Publication: 2011 May 11.